Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FLORBETABEN F-18
- A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
- PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using PI-2620
- Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury
- Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis
- Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
- Frontline Lenalidomide for AL Amyloidosis Involving Myocardium
- Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT
- Metformin in Alzheimer's Dementia Prevention
- Detection of Amyloidosis in Multiple Myeloma Patients by [18F]Florbetaben Positron Emission Tomography
- Imaging Inflammation in Alzheimer's Disease With 11C-ER176
- Assessment of 18F-Florbetaben Whole-body PET for the Detection of Cardiac and Extracardiac Sites of Amyloid Deposits
- Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
- PET/MRI Evaluation of Cardiac Amyloid
- Subjects With Subjective Cognitive Decline: 18F-Florbetaben Positron Emission Tomography Study
- Imaging Inflammation in Alzheimer's Disease
- Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD
- Imaging of Cognition, Learning, and Memory in Aging
- Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172
- Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
- Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients
- Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology
- Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.
- Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers
Clinical trials list
click for details